KTTA Pasithea Profit After Tax
The implementation of software robots for processing CNS clinical trial data defines the development vector for Pasithea Therapeutics (KTTA). The company's current profit level demonstrates financial stability, with the indicator fixed at -0.02. Capitalization relies on a network of ketamine therapy clinics, while small molecule patents and grants ensure a steady inflow of free cash flow.
Comprehensive metric breakdowns and analytics for pasitheaclinics.com (KTTA)
- stock value and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Pasithea Therapeutics|KTTA - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Pasithea Therapeutics Corp.|KTTA - Company Aggregate Debts|Debt to Net Assets Ratio Pasithea Therapeutics Corp.|KTTA - Company Long-Term Debts|Short-Term Debt Pasithea Therapeutics|Quick Ratio pasitheaclinics.com
- earnings and market multiples details:
Fundamental valuation:Pasithea (KTTA)
The integration of ESG standards into Pasithea Therapeutics (KTTA) neurodisease research directly impacts operational efficiency, as reflected by the company's profit level of -0.02. This indicator measures net cash flow after all expenses, allowing investors to compare the business's actual yield with market demand for shares to optimize entry timing into the asset.
Direct competitors
Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|regencellbioscience.com - Profit After Tax|Net Profit AXSM|Net Profit ACADIA Pharma (ACAD)|Company Net Income Xenon Pharmaceuticals Inc XENE|Net Financial Result Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|DNLI (Denali Therapeutics Inc.) - Net Income|HRMY: Profit After Payment of Taxes|BHVN (Biohaven Pharmaceutical) - Net Profit|AMLX: Final Profit|Net Profit TRVI|PRAX - Company Net Income|Net Profit AVXL (Anavex Life Sciences Corp.)|Net Profit CeriBell Inc CBLL|PRTA: Net Income|Final Profit ALEC (Alector, Inc.)|ANNX (Annexon, Inc.) - Net Income|OMER: Profit After Payment of Taxes|NGNE (Neurogene) - Net Profit|ACIU: Final Profit|Net Profit VYGR|NMRA - Company Net Income|Company Net Income Scilex Holding Company SCLX|Final Profit TVGN|Alpha Cognition Corp - Net Profit|CGTX - Net Profit|Inhibikase (IKT) - Company Net Income|Profit After Tax SAVA (Cassava Pharma)|ASRT (Assertio Holdings) - Net Profit|Company Net Income Coya COYA|Net Income VTGN (Vistagen Therapeutics)|Net Profit ovidrx.com (OVID)|Acumen Pharma - Net Income|Profit After Payment of Taxes CRVO (CervoMed Corporation)|Alterity Therapeutics Ltd - Net Profit|Net Financial Result Clene Inc. CLNN|PEPG: Net Profit|Net Income jupiterneurosciences.com|Company Net Income Relmada|Annovis Bio Corporation (ANVS) - Net Financial Result|Company Net Income Grace Therapeutics, Inc. (GRCE)|Net Profit fireflyneuro.com (AIFF)|Klotho Neurosciences - Net Income|Profit After Payment of Taxes NRSN (NeuroSense Therapeutics Ltd)|RVPH: Net Income|MetaVia Inc - Profit After Payment of Taxes|NRXS: Net Profit|Helius Medical Technologies (HSDT) - Net Profit|Company Net Income Passage Bio Inc.|Company Profit NEUP (Neuphoria)|Net Profit NERV|ATHA - Company Net Income|Addex Therapeutics - Net Income|Net Profit Alzamend Neuro Inc. ALZN|CYCN - Company Net Income|Final Profit PTIX (Protagenic Therapeutics)|cortigent.com (CRGT) - Company Net Income|Company Net Income Avenue Therapeutics Inc (ATXI)|Company Net Income Brainstorm Cell|caratherapeutics.com - Profit After Tax|Net Profit CHRO|Net Profit eliemtx.com (ELYM)|Company Net Income Intra-Cellular Therapies, Inc. ITCI|Net Financial Result Longboard (LBPH)|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|SAGE: Profit After Payment of Taxes|SNPX (Neurotrope) - Net Profit|TRVN: Final Profit|Net Profit VIGL|WENA - Company Net Income|Net Profit CERE (Cerevel Therapeutics, Inc.)